We are live on
!
Find out more
Atossa Therapeutics
ATOS
ATOS
14 hedge funds and large institutions have $765K invested in Atossa Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.56% less ownership
Funds ownership: 0.92% → 0.36% (-0.56%)
4% less capital invested
Capital invested by funds: $798K → $765K (-$32.6K)
22% less funds holding
Funds holding: 18 → 14 (-4)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
14
Holders Change
-4
Holders Change %
-22.22%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
2
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$513K |
| 2 |
VF
Virtu Financial
New York
|
-$65.2K |
| 3 |
Barclays
London,
United Kingdom
|
-$48.9K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$35K |
| 5 |
Jane Street
New York
|
-$23K |
